Your browser doesn't support javascript.
loading
Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.
Boekholdt, S Matthijs; Hovingh, G Kees; Mora, Samia; Arsenault, Benoit J; Amarenco, Pierre; Pedersen, Terje R; LaRosa, John C; Waters, David D; DeMicco, David A; Simes, R John; Keech, Antony C; Colquhoun, David; Hitman, Graham A; Betteridge, D John; Clearfield, Michael B; Downs, John R; Colhoun, Helen M; Gotto, Antonio M; Ridker, Paul M; Grundy, Scott M; Kastelein, John J P.
Afiliación
  • Boekholdt SM; Department of Cardiology, Academic Medical Center, Amsterdam, the Netherlands.
  • Hovingh GK; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
  • Mora S; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts.
  • Arsenault BJ; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
  • Amarenco P; Department of Neurology and Stroke Center, Bichat University Hospital, Paris, France.
  • Pedersen TR; Center of Preventive Medicine, Oslo University Hospital, Ulleval and University of Oslo, Oslo, Norway.
  • LaRosa JC; Health Science Center, State University of New York, Brooklyn, New York.
  • Waters DD; Division of Cardiology, San Francisco General Hospital and the University of California at San Francisco, San Francisco, California.
  • DeMicco DA; Global Pharmaceuticals, Pfizer Inc., New York, New York.
  • Simes RJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Keech AC; NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia.
  • Colquhoun D; The Wesley Hospital, Brisbane, Australia.
  • Hitman GA; Centre for Diabetes, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
  • Betteridge DJ; Department of Endocrinology and Diabetes, University College Hospital, London, United Kingdom.
  • Clearfield MB; Touro University, Mare Island, California.
  • Downs JR; Department of Medicine, University of Texas Health Science Center, San Antonio, Texas; VERDICT, South Texas Veterans Health Care System, San Antonio, Texas.
  • Colhoun HM; Medical Research Institute, University of Dundee, Dundee, United Kingdom.
  • Gotto AM; Weill Cornell Medical College, New York, New York.
  • Ridker PM; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, Massachusetts.
  • Grundy SM; Center for Human Nutrition, Southwestern Medical Center, University of Texas, Dallas, Texas.
  • Kastelein JJ; Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands. Electronic address: j.j.kastelein@amc.uva.nl.
J Am Coll Cardiol ; 64(5): 485-94, 2014 Aug 05.
Article en En | MEDLINE | ID: mdl-25082583
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis / Lipoproteínas Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Ensayos Clínicos Controlados Aleatorios como Asunto / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis / Lipoproteínas Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Am Coll Cardiol Año: 2014 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos